ESPR

MKT CAP:$806M

Esperion Therapeutics Inc

Market Cap

$806M

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Healthcare·Drug·🇺🇸·NASDAQ

Stock Price

$3.13-$0.58 (-15.63%)

Jun 5, 2026

52W High $4.0852W Low $0.98

Company Details

Esperion Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products in...

CEO

—

IPO Date

Jun 26, 2013

Website

www.esperion.com

Key Metrics TTM

Revenue

$418M

+61.1% YoY

Net Income

-$7M

EPS (Diluted)

Free Cash Flow

-$18M

Revenue / Share

$1.66

Gross Margin

65.0%

Operating Margin

18.1%

Net Margin

-1.8%

FCF Margin

-4.3%

P/S

1.9x

P/E

Earnings Reports

Q2 2026

Aug 4, 2026

PENDING

Q1 2026

May 8, 2026

$80M+23.2%

FY 2025

Mar 10, 2026

$403M+21.3%

Q4 2025

Mar 10, 2026

$168M+143.7%

Q3 2025

Nov 6, 2025

$87M+69.1%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee